Caplin Point Laboratories logo

Caplin Point Laboratories financials and balance sheet

NSE: CAPLIPOINTBSE: 524742Pharmaceuticals & BiotechnologySmall Cap

Last close ₹2,222.00down ₹27.10 (1.20%)BSE ₹2,222.15

Share price at the NSE close on 23 Oct 2026. Previous close ₹2,249.10.

52-week range of traded prices to 23 Oct 2026
₹1,500.30Low, 30 Mar 2026₹2,990.00High, 24 Sep 2026
Market cap
₹16,890 Cr453rd largest listed
P/E
25.4
P/B
4.7
Dividend yield
0.36%
ROE
20.7%
ROCE
19.8%
Debt to equity
0.00
Volume, NSE
76,90447.0% delivered

10 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Caplin Point Laboratories annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹2,187 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue2,187
  2. Materials and goods−866
  3. Employee costs−199
  4. Other expenses−362
  5. Operating profit761
  6. Depreciation−73
  7. Other income+116
  8. One-off items0.0
  9. Finance costs−0.9
  10. Profit before tax803
  11. Tax−153
  12. Net profit650

What the company owns

  • Plant, investments and other assets₹1,784 Cr
  • Receivables₹826 Cr
  • Cash and bank₹621 Cr
  • Inventory₹429 Cr
  • Current investments₹386 Cr

What pays for it: net worth and liabilities

  • Net worth₹3,631 Cr
  • Owed to suppliers₹296 Cr
  • Other liabilities₹118 Cr
  • Borrowings₹1 Cr

Caplin Point Laboratories business segments, year to Mar 2026

A reportable segment is a line of business the company must report on its own. Consolidated, ₹ crore, as the company reports them.Caplin Point Laboratories segment results by quarter

Revenue by segment

₹2,187 CrTotal
  • Rest of the World₹1,734 Cr79.3% of total
  • USA₹453 Cr20.7% of total

Profit by segment

  • Rest of the World₹631 Cr91.8% of total
  • USA₹56 Cr8.2% of total

Segment results by year

Consolidated from the year to Mar 2021, standalone before, ₹ crore, years to March.

  • Rest of the World

    Revenue, ₹ crore
    Profit, ₹ crore
  • USA

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue of all businesses––––––1,9372,187
Company revenue, as in its results6495281,0611,2691,4671,6941,9372,187
Revenue––––––1,5831,734
Revenue growth–––––––9.5%
Profit––––––540631
Profit growth–––––––16.8%
Margin––––––34.1%36.4%
Return on capital––––––45.8%39.8%
Assets––––––1,4491,918
Liabilities––––––269333
Capital employed––––––1,1801,586
Revenue––––––355453
Revenue––––––96116
Profit is before tax and finance costs, the way companies report their segments.

Profit and loss

Consolidated, ₹ crore, years to March.Caplin Point Laboratories quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 27 MayMar 2020Mar 2021Filed 7 MayMar 2022Filed 13 MayMar 2023Filed 27 MayMar 2024Filed 17 MayMar 2025Filed 10 JunMar 2026Filed 14 May
Revenue from operations4055406498631,0611,2691,4671,6941,9372,187
2763454176037338751,0261,1431,2911,426
Materials and goods bought185238289413472558663724771866
Employee costs30394768103115137144178199
Other expenses616881122158202225275342362
Operating profit before depreciation129195231260329395441551647761
Operating margin31.8%36.1%35.7%30.1%31.0%31.1%30.1%32.6%33.4%34.8%
Materials, % of revenue45.7%44.1%44.5%47.9%44.4%43.9%45.2%42.7%39.8%39.6%
Employee costs, % of revenue7.4%7.3%7.3%7.8%9.7%9.1%9.3%8.5%9.2%9.1%
Other expenses, % of revenue15.2%12.6%12.6%14.2%14.9%15.9%15.4%16.2%17.7%16.5%
Depreciation and amortisation13192332374745536673
Operating profit after depreciation116176208228292348396498581688
Other income61319412439566796116
Finance costs0000211111
Profit before one-off items and tax122188227269314386451564677803
One-off items0000000000
Profit before tax122188227269314386451564677803
26445054627774103136153
Share of profit of joint ventures and associates––––––––0–
96145177215251308377461541650
Other comprehensive income––0–−714431127142
Total comprehensive income––176–244323420473568791
Net margin23.7%26.8%27.2%24.9%23.7%24.3%25.7%27.2%27.9%29.7%
Net margin without joint ventures and associates––––––––27.9%–
Share of profit of joint ventures and associates is left blank for the years to Mar 2024 and Mar 2026: the filing states 0 for this share both for the period and for the year so far, which the form also writes for a line it does not fill, while the company's other filings for the same year show it was not 0 over those months.

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2019Filed 27 MayMar 2020Mar 2021Filed 7 MayMar 2022Filed 13 MayMar 2023Filed 27 MayMar 2024Filed 17 MayMar 2025Filed 10 JunMar 2026Filed 14 May
633–1,2031,5101,9072,3472,8863,631
633–1,1861,4841,8802,3162,8503,586
Share capital15–151515151515
Reserves618–1,1711,4691,8652,3012,8353,571
Belonging to outside owners of subsidiaries0–182627313644
0–1713111
86–143208268331306386
23–171916201629
Total assets743–1,3641,7362,1912,6973,2094,045
249–3284396378051,0751,460
494–1,0361,2981,5541,8922,1342,586
Net debt−222–−453−514−649−790−902−1,006
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017, Mar 2018 and Mar 2020, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2021Filed 7 MayMar 2022Filed 13 MayMar 2023Filed 27 MayMar 2024Filed 17 MayMar 2025Filed 10 JunMar 2026Filed 14 May
269337272311432523
341418363424563668
6−12−146−158−146−250
Receivables−50−41−74−149−88−179
Inventories59−48−61−7527−93
Payables31843269−2969
Other working capital−34−7−43−4−57−48
Tax paid−66−82−88−109−131−145
Capital spending091194146192248
Free cash flow26924678165241275
−8−271−218−313−335−582
−24−41−28−38−38−46
Dividends paid32330343846
Shares bought back000000
Shares issued000000
Net change in cash2362526−4059−106
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Consolidated, ₹ per share, years to March.Caplin Point Laboratories dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 27 MayMar 2020Mar 2021Filed 7 MayMar 2022Filed 13 MayMar 2023Filed 27 MayMar 2024Filed 17 MayMar 2025Filed 10 JunMar 2026Filed 14 May
Earnings per share₹12.72₹19.26₹23.35₹28.42₹32.03₹39.61₹49.62₹60.19₹70.57₹84.36
Diluted earnings per share₹12.72₹19.16₹23.23₹28.20₹31.71₹39.26₹49.18₹59.90₹70.25₹84.11
Dividend per share₹1.50₹2.00₹2.20₹2.50₹3.00₹4.00₹4.50₹5.00₹6.00₹8.00
Book value per share––₹83.68–₹156.75₹195.77₹247.76₹304.90₹375.06₹471.90
Dividend payout11.8%10.5%9.4%8.8%9.4%9.8%9.1%8.3%8.5%9.5%
Shareholder yield––––0.1%0.4%0.7%0.3%0.2%0.4%
Market cap at the year end (₹ crore)2,9344,3043,0372,1363,0525,1394,5239,98915,20111,438
RatioMar 2017Mar 2018Mar 2019Filed 27 MayMar 2020Mar 2021Filed 7 MayMar 2022Filed 13 MayMar 2023Filed 27 MayMar 2024Filed 17 MayMar 2025Filed 10 JunMar 2026Filed 14 May
Revenue growth–33.3%20.2%33.1%22.9%19.6%15.5%15.5%14.4%12.9%
Operating profit growth–51.2%18.8%12.4%26.4%20.1%11.8%25.0%17.3%17.6%
Net profit growth–50.4%22.1%21.8%16.9%22.7%22.2%22.4%17.3%20.1%
Earnings per share growth–51.4%21.2%21.7%12.7%23.7%25.3%21.3%17.2%19.5%
––27.9%–20.4%23.1%22.4%21.8%20.8%19.9%
–––––2.7 pts−0.7 pts−0.6 pts−1.0 pts−0.8 pts
From the net margin–––––1.3 pts1.3 pts1.2 pts0.6 pts1.2 pts
From asset turnover–––––1.1 pts−2.1 pts−1.7 pts−1.2 pts−1.8 pts
From borrowing–––––0.2 pts0.1 pts0.0 pts−0.4 pts−0.3 pts
Return on capital employed––32.8%–23.9%23.0%20.7%21.2%20.1%18.9%
Cash conversion––––106.8%109.2%72.1%67.4%79.9%80.5%
Interest cover902.52,881.53,465.1713.9183.4496.8507.8638.5952.4790.9
Debt to equity––0.00–0.010.000.000.000.000.00
Receivable days––90–969298117119138
Inventory days––47–138149159183159181
Payable days––76–6810790106103125
Cash conversion cycle, days––61–166134166194175194
Working capital days––104–151166159166174199
Asset turnover––0.87–0.780.820.750.690.660.60
Assets per rupee of net worth––1.17–1.151.161.171.171.141.13
Sales per rupee of plant––2.89–3.574.595.493.863.653.99
Capital spending to depreciation––––0.001.944.312.732.903.41
Plant being built, % of plant in use––4.3%–4.7%5.6%82.6%26.6%26.3%38.1%
No balance sheet is on record for the years to Mar 2017, Mar 2018 and Mar 2020, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
17.7%
Cash from operations against operating profit
68.8%
Measure10 years5 years3 years
Revenue growth, yearly rate–15.6%14.2%
Profit growth, yearly rate–21.5%19.4%
Return on equity, average–21.6%20.8%
Return on capital employed, average–20.8%20.1%
Operating margin, average32.7%32.4%33.6%
Net margin, average26.1%27.0%28.3%
Asset turnover, average–0.700.65
Cash conversion cycle, days, average–173188
Interest cover, average1,153.3677.3793.9
Debt to equity, average–0.000.00

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations1,8751,267523
Cash from investing−1,718−1,230−582
Cash from financing−192−123−46
Capital spending870585248
Dividends paid17111846
Shares bought back000
Shares issued for cash000
Borrowings raised––0
Borrowings repaid1700

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––––2355
Altman Z-scorePublished threshold 1.81––20.35–14.9617.0212.8020.3131.5219.63
Beneish M-scorePublished threshold −1.78–––––−1.55−1.69−2.04−2.16−1.95
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–––––15.6516.4618.9415.0219.54
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––0.940.800.740.77
Receivables growth less revenue growthOur threshold 0 percentage points–––––−5.047.5822.222.1817.68
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––––8.817.8416.77−13.8615.30
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––––17.89−1.09−1.403.452.82
Assets under construction, years of additionsOur threshold 2 years of additions–––––0.586.240.520.882.32
Effective tax ratePublished threshold 17.16 per cent21.1323.2222.1820.1819.8320.0516.4818.2520.0519.07
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––−1.07−3.06−1.090.751.07
A threshold marked as ours has no published figure; it is the line we read the check against.